Dova is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates where there is a high unmet medical need. DOPTELETÂŽ (avatrombopag) is an orally administered thrombopoietin receptor agonist that we are developing for the treatment of thrombocytopenia across many different patient types. Source
No articles found.
We enable cheaper, faster, and better genetic engineering of plants. We offer our ...
We enable cheaper, faster, and better genetic e...
La Jolla Pharmaceutical Company is a publicly traded biopharmaceutical company foc...
La Jolla Pharmaceutical Company is a publicly t...
Change Healthcare is a leading independent healthcare technology company that prov...
Change Healthcare is a leading independent heal...
At MannKind Corporation (NASDAQ: MNKD), we focus on the discovery, development and...
At MannKind Corporation (NASDAQ: MNKD), we focu...
Join the National Investor Network and get the latest information with your interests in mind.